Inhibition of the PD‐1/PD‐L1 axis enhances antitumor immunity in order to prevent tumor cells escaping from host immune responses, thereby providing a promising strategy for effective tumor immunotherapy.4 The gene discussed is PDCD1; the disease is neoplasm.